Cargando…

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry

Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Battrawy, Ibrahim, Kovacs, Boldizsar, Dreher, Tobias C., Klein, Norbert, Rosenkaimer, Stephanie, Röger, Susanne, Kuschyk, Jürgen, Saguner, Ardan Muammer, Kowitz, Jacqueline, Erath, Julia W., Duru, Firat, Akin, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881447/ https://www.ncbi.nlm.nih.gov/pubmed/35217697 http://dx.doi.org/10.1038/s41598-022-06007-y

Ejemplares similares

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2023)

The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up
por: Rosenkaimer, Stephanie L., et al.
Publicado: (2020)

Wearable Cardioverter–Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac Rehabilitation
por: Kovacs, Boldizsar, et al.
Publicado: (2021)

Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting
por: Röger, Susanne, et al.
Publicado: (2018)

High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry
por: Kovacs, Boldizsar, et al.
Publicado: (2021)

Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?
por: Kovacs, Boldizsar, et al.
Publicado: (2018)

Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype–phenotype Correlation and Pathophysiology
por: Fan, Xuehui, et al.
Publicado: (2023)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
por: Israel, Carsten, et al.
Publicado: (2022)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
por: Vinas, Ariel, et al.
Publicado: (2021)

Phantom Shocks Associated With a Wearable Cardioverter Defibrillator
por: Delle Donna, Paul, et al.
Publicado: (2021)

Experience with a Wearable Cardioverter-defibrillator in 436 Patients
por: Nägele, Herbert, et al.
Publicado: (2022)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
por: Blaschke, Florian, et al.
Publicado: (2021)

Takotsubo Syndrome: Translational Implications and Pathomechanisms
por: Fan, Xuehui, et al.
Publicado: (2022)

Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
por: Wan, Chingping, et al.
Publicado: (2013)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Wearable Cardioverter Defibrillator　― Initial Experience in the Outpatient Setting in Japan ―
por: Horiguchi, Ai, et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is needed for most high-risk patients
por: Lee, Byron K.
Publicado: (2020)

Update on Wearable Cardioverter Defibrillator: A Comprehensive Review of Literature
por: Alsamman, Mrhaf, et al.
Publicado: (2022)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
por: Sinha, Anil-Martin, et al.
Publicado: (2020)

A wearable cardioverter defibrillator with a low false alarm rate
por: Poole, Jeanne E., et al.
Publicado: (2022)

The wearable cardioverter‐defibrillator—Improving comfort and reaching towards noise immunity
por: Varma, Niraj
Publicado: (2022)

Epidural Blood Patch Placement with Patient Wearing Wearable Cardioverter Defibrillator: To be or Not to be
por: Gupta, Deepak
Publicado: (2023)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

The Gulf Implantable Cardioverter-defibrillator Registry: Rationale, Methodology, and Implementation
por: Alsheikh-Ali, Alawi A., et al.
Publicado: (2015)

Long‐term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction
por: Röger, Susanne, et al.
Publicado: (2018)

Incidence, recurrence and management of electrical storm in Brugada syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
por: Wäßnig, Nadine K., et al.
Publicado: (2016)

Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator
por: Skowasch, Dirk, et al.
Publicado: (2018)

Outcomes after asystole events occurring during wearable defibrillator-cardioverter use
por: Liang, Jackson J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tgs0diobdmqf6d0it62v28c328